Keloids and hypertrophic scars--immunological aspects

Area of Science:

• Immunology
• Dermatology
• Cell Biology

Background:

• Keloids and hypertrophic scars are common fibroproliferative disorders of wound healing.
• Distinguishing between keloids and hypertrophic scars can be clinically challenging.
• Previous research has explored immunological differences, but definitive markers are lacking.

Purpose of the Study:

• To investigate the presence of antinuclear antibodies (ANA) in patients with keloids compared to hypertrophic scars.
• To identify potential immunological differences that could aid in the differential diagnosis of keloids and hypertrophic scars.

Main Methods:

• Acid elution technique was used to isolate lymphoid blood cells.
• Immunofluorescence studies were performed to detect antinuclear antibodies.
• ELISA assays were conducted to detect specific antibody classes.

Main Results:

• Antinuclear antibodies (ANA), belonging to one or more of the 5 main immunoglobulin classes, were detected in eluates from 20 keloid patients.
• These detected ANAs were predominantly directed against fibroblasts.
• No antinuclear antibodies were detectable in eluates from 7 hypertrophic scar patients or 40 healthy controls.

Conclusions:

• The presence of specific antinuclear antibodies (ANA) targeting fibroblasts is a significant differentiator between keloids and hypertrophic scars.
• Immunological detection of ANA offers a potential diagnostic tool for distinguishing keloids from hypertrophic scars.
• Further research is warranted to explore the precise role of these autoantibodies in keloid pathogenesis.